Indeed, downregulation of several glycolysis genes deeply involved in cancer progression (ENO1, ME1, SLC2A4RG, PFKL and DLAT) [42–47] was confirmed by RT-qPCR in siRNF40-treated HCC1806 cells (Fig. 6D, Fig. S2C). This evidence concerns the gene DLAT and cancer.